---
title: "PTHS.US (PTHS.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/PTHS.US/news.md"
symbol: "PTHS.US"
name: "PTHS.US"
parent: "https://longbridge.com/en/quote/PTHS.US.md"
datetime: "2026-03-10T05:23:28.653Z"
locales:
  - [en](https://longbridge.com/en/quote/PTHS.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/PTHS.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/PTHS.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/PTHS.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/PTHS.US/news.md)


# PTHS.US (PTHS.US) — Related News

### [This Jazz Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday](https://longbridge.com/en/news/277237712.md)
*2026-02-27T18:03:49.000Z*
> Top analysts have initiated coverage on several stocks with bullish ratings. Barclays analyst Etzer Darout rated Jazz Ph

### [Pelthos Therapeutics Inc - To Offer Securities Up To $200 Million](https://longbridge.com/en/news/274562427.md)
*2026-02-02T21:55:44.000Z*
> Feb 2 (Reuters) - Pelthos Therapeutics Inc (PTHS.A) :* PELTHOS THERAPEUTICS INC - TO OFFER SECURITIES UP TO $200 MILLION

### [PEPTONIC Medical AB Delays Year-End Report Release](https://longbridge.com/en/news/274135175.md)
*2026-01-29T10:45:18.000Z*
> PEPTONIC Medical AB has announced a delay in the release of its year-end report. Specific details regarding the financia

### [Tenpoint Therapeutics Secures $235 Million through Series B Stock Financing and Credit Facility to Accelerate Commercialization of YUVEZZI™](https://longbridge.com/en/news/274083469.md)
*2026-01-29T03:23:02.000Z*
> Tenpoint Therapeutics has secured $235 million through Series B stock financing and a credit facility to accelerate the 

### [Thiogenesis Presents Phase 2 (EU) MELAS Data at Mitocon 2026 | TTIPF Stock News](https://longbridge.com/en/news/273524672.md)
*2026-01-23T06:00:00.000Z*
> Thiogenesis Therapeutics presented interim data from its Phase 2 (EU) study of TTI-0102 for MELAS at Mitocon 2026. The s

### [Johnson & Johnson reports 9.1% increase in sales for Q4 2025](https://longbridge.com/en/news/273364133.md)
*2026-01-22T10:03:17.000Z*
> Johnson & Johnson reported a 9.1% increase in Q4 2025 sales, with full-year sales growing by 6% to $94.2bn. Q4 diluted E

### [17:31 ET
			
			
				Cystinosis Market to Grow at a Substantial Growth Rate of 5.1% During the Forecast Period (2025-2034) | DelveInsight](https://longbridge.com/en/news/273288856.md)
*2026-01-21T22:32:12.000Z*
> DelveInsight's report indicates that the cystinosis market is projected to grow at a rate of 5.1% from 2025 to 2034, wit

### [Horizon Technology Finance Provides $50 Million Venture Loan Facility to Pelthos Therapeutics](https://longbridge.com/en/news/272746272.md)
*2026-01-15T21:10:17.000Z*
> Horizon Technology Finance Corporation has provided a $50 million venture loan facility to Pelthos Therapeutics Inc., wi

### [Pelthos Therapeutics Secures $50 Million Loan Facility from Horizon Technology Finance](https://longbridge.com/en/news/272420271.md)
*2026-01-13T13:32:20.000Z*
> Pelthos Therapeutics Inc. has secured a $50 million senior secured term loan facility from Horizon Technology Finance Co